Atlas Trials

Safety and Efficacy of ALV003 for the Treatment of Celiac Disease

Clinical trial NCT00959114 · COMPLETED

Trial details

NCT number
NCT00959114
Sponsor
Alvine Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2009-08-01
Primary completion
2010-08-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.